TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Cognitive deficits relevant to daily living (I-ADL score)
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Frequency of minor complications
Endpoint domain: Adverse events/effects
Primary endpoint: Vlc score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: daily life ability improvement
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: degree of disability improvement
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: BML volume regression
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of total knee arthroplasty
Endpoint domain: Adverse events/effects
Primary endpoint: Ethical activity profile
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: serum potassium concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Electrolyte outcomes
Primary endpoint: 6-month LLL
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: void frequency
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Cure after treatment
Endpoint domain: Mortality/survival
Primary endpoint: Incidence of thrush
Endpoint domain: Adverse events/effects
Primary endpoint: Incidence of ventilator-associated pulmonary infection
Endpoint domain: Adverse events/effects
Primary endpoint: Dice coefficient for segmentation accuracy
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cohen’s kappa for agreement on infection volume changes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Communication Assessment Tool scores
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Increase in SP, CGRP, and VEGF expressions
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: OSDI score change
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: SANDE score change
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: 5‐Item Dry Eye Questionnaire score (DEQ5)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: tear breakup time
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: glands expressibility
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: β-cell function measured by C-peptide oDI
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Insulin sensitivity (IS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Glycemic failure rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean numerical rating scale (NRS) score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of moderate‐to‐severe pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pain management index (PMI) score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean increase in TIS score of antihypertensive medications
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of antihypertensive medications
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: DPP‐4 enzyme inhibition over time (DPP‐4‐AUEC0‐24)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean sick leave
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Single procedure freedom from AF/atrial tachycardia (AT) ≥30 s without anti‐arrhythmic drugs
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Levels of PAR
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Viral shedding of infectious type 2 virus
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: score of smell identification
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: plasma concentration of melatonin
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Median time to molecular recurrence (≥MMR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pain knowledge
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Absence of most bothersome symptom
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: RSI score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: RFS
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: 24 h esophageal pH<4 time proportion
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Proportion obtaining a clinically important reduction of 1 h of crying
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: GRAVo score for predicting PEG tube placement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: alloimmunization incidence against Rh blood group antigens
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Serrated Lesion Detection Rate (SLDR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: More Serrated Lesions Found per Procedure (MSP)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Motor function scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Percentage of patients with elevated tumor markers
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: 3-year RFS (recurrence-free survival)
Endpoint domain: Mortality/survival
Primary endpoint: Efficacy of intranasal oxytocin as an anti-obesity medication
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: time to in vitro thrombotic occlusion under high shear stress
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: percent of changes in forced expiratory volume (FEV1)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Positive response to Rengalin
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Double decrease of cough severity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Total CAT score decrease
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Hippocampal glutamate levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cumulative major amputation-free survival (MAFS) rate
Endpoint domain: Mortality/survival
Primary endpoint: Anti-drug antibody positivity
Endpoint domain: Adverse events/effects
Primary endpoint: Recession
Endpoint domain: Physiological/clinical
Primary endpoint: time-averaged pain intensity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: standardised function score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Skill performance scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Fit of the WLQ-25 to the Rasch model
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Preference-based patient participation
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Aortic valve leaflet fusion length
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of PPCs at 14 Days
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Total score for climacteric symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Scores for insomnia
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Scores for sexual disorders
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: hip torque
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: gametocyte clearance rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Satisfaction with surgical outcomes
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: change in hemodynamics
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Effect of perioperative vaginal estrogen on surgical repair outcomes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Change in SAPS-PD score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: CGI-I response rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: composite net clinical outcome
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: PSS-10 scores
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Ankle-Hip Index (AHI)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Force-Time Integral (FTI)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: frequency of stent postdilation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: stent size selection
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Appearance of the sinuses
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Improvement in dyssynergic defecation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Reduction in use of medications
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Intelligibility
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Easier chewing
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Lower average number of prosthesis maintenance
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: AFF score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Improvement in communication skills
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: mean horizontal deviation at the entry point (DE)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: mean angular deviation (DA)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: mean depth deviation (DD)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: suicide rates
Endpoint domain: Mortality/survival
Primary endpoint: Rates of grade ≥2 acute or late toxicities
Endpoint domain: Adverse events/effects
Primary endpoint: food intake at lunch
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: energy intake throughout the day
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean of COP displacement in the y-axis
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Systemic exposure to budesonide
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Maximum plasma concentration of budesonide
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of resorption craters
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Volume of resorption craters
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Toilet use
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Physical capacity improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Follow-up mortality prediction
Endpoint domain: Mortality/survival
Primary endpoint: Pre-transplantation circulating levels of CLEC4C
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Incidence of catheter malfunction
Endpoint domain: Adverse events/effects
Primary endpoint: Mortality associated with NLR ≥4
Endpoint domain: Mortality/survival
Primary endpoint: buccal mucosal thickness
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: profilometric changes of buccal soft tissues
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: VSCs levels after mouthwash administration
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of patients free from bad smell
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: motilin hormone levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: secretin hormone levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: cholecystokinin hormone levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: cardiac output
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: right atrial pressure
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pharmacokinetic parameters (maximum plasma concentration and area under the plasma concentration–time curve)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Fasting valine and isoleucine levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Postprandial area under the curve (AUC) of leucine
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Latency from sleep onset to N2 and N3 sleep stages
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: composite of unplanned hospital admission or death by 24 months
Endpoint domain: Mortality/survival
Primary endpoint: in-hospital COVID-19 related mortality
Endpoint domain: Mortality/survival
Primary endpoint: Serological response rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Anti-HBs titers greater than 100 IU/L
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Protective anti-HBs at 1-year follow-up
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Rescue opioid use
Endpoint domain: Adverse events/effects
Primary endpoint: Numeric Pain Scale (NPS) values
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: safety of bosentan
Endpoint domain: Adverse events/effects
Primary endpoint: Body weight measurements
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Caregiver Priorities & Child Health Index of Life with Disabilities
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Decrease in time spent engaging in problematic pornography use
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Decrease in anxiety, depression and obsessive‐compulsive symptoms
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Weight for age z-scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Increase in Physical Activity (PA)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction in Sedentary Behavior (SB)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: All-cause mortality at day 30
Endpoint domain: Mortality/survival
Primary endpoint: All-cause mortality at day 180
Endpoint domain: Mortality/survival
Primary endpoint: Ischaemic complications at day 30
Endpoint domain: Mortality/survival
Primary endpoint: static posturographic stability score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: DHI
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: VAS pain scores during surgery
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Quality of operating conditions
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: End-diastolic interventricular septum thickness
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Peak systolic and early diastolic annular velocity of the left ventricle
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Knee and hip extension moments
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: overall RLS severity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean exercise training intensity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Health-Related Quality of Life (HRQoL) improvements
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: days of moderate or severe ILS during influenza-like illness episodes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Event transmission time
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Percentage of diagnosed patients
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Frequency of event detections
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Hospital readmission rate
Endpoint domain: Mortality/survival
Primary endpoint: Adherence to medication changes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Chlamydia positivity rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Gonorrhoea positivity rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Patient acceptability of NLTM
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Agreement of Peak Day identification
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Utilization of adolescent-friendly services
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Hospitalization or ED visit within 29 days
Endpoint domain: Mortality/survival
Primary endpoint: Total blastulation rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Reproductive system and breast outcomes
Primary endpoint: Day of blastulation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Reproductive system and breast outcomes
Primary endpoint: TIMI 3 flow in the infarct-related artery before pPCI
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Complete ST-segment resolution 1 hour after pPCI
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Rate of perineal lacerations
Endpoint domain: Adverse events/effects
Primary endpoint: Self-assessed psychosocial functioning
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Number of injected packed cells
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Initiation of oral feeding (IOF) time
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Non-nutritive sucking (NNS) score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 1- and 3-year survival rate
Endpoint domain: Mortality/survival
Primary endpoint: Change in PANSS hostility item score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: length of catheter dwell time
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: procedure time to discharge
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of infants discharged without tube-feeding
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: POFRAS score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: mean resting heart rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: heart-rate variability
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Incidence of late grade ≥3 US
Endpoint domain: Adverse events/effects
Primary endpoint: treatment use
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Rates of DR improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Risk of new PDR-related events
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: BCVA gain of >=15 letters
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: mean scores of clinical skills in providing sexual health counseling services
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: AUC0‐24,ss
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: lumbar areal bone mineral density
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: RSAB Total Score
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: CRF
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: osseointegration speed index
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: VS response to rewards
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of dry nights
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes